-
Women in Medicine Conference Celebrates Empowerment and Successes
Women in the healthcare field and their allies convened in the Feinberg Pavilion at Northwestern Memorial Hospital to celebrate women’s empowerment and success during the sixth annual Women in Medicine Conference on March 8.
-
Mutation Provides Insights Into Mechanisms of Neurodegeneration in Parkinson’s Disease
A mutated protein expressed in lysosomes may contribute to Parkinson’s disease, according to a new Northwestern Medicine study published in the Journal of Cell Biology.
-
Evaluating Outcomes of Extended Thrombolytic Therapy for Ischemic Stroke
Thrombolytic therapy administered longer after the onset of ischemic stroke than current recommendations did not demonstrate improved clinical outcomes as compared to placebo, according to a recent trial published in the New England Journal of Medicine.
-
Shape-Shifting Ultrasound Stickers Detect Post-Surgical Complications
Investigators have developed a new, first-of-its-kind sticker that enables clinicians to monitor the health of patients’ organs and deep tissues with a simple ultrasound device.
-
Release of Inhibitory Pathways May Promote Immune Response to HIV
Recent work from the laboratory of Elena Martinelli, PhD, MPH, has discovered how inhibiting an immune cell singling pathway in a model of HIV-1 infection may promote immune responses and decrease viral persistence in conjunction with antiretroviral therapy.
-
Study Examines Delayed Pediatric Diagnoses in Emergency Departments
Emergency departments that see fewer pediatric patients are more likely to give delayed diagnoses for serious medical conditions compared to those who see pediatric patients more often, according to a Northwestern Medicine study published in JAMA Pediatrics.
-
Innate Immune Cells Promote Growth of Blood Vessels in Colon Cancer
A type of white blood cell is responsible for growth and branching of blood vessels which supports tumor growth in colon cancer, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.
-
New Drug Shows Promise for Treating Rare Brain Tumors
An experimental drug may provide a new treatment option for some patients with rare incurable brain tumors, according to an analysis published in the Journal of Clinical Oncology.
-
Treating Skin Cancer Without Risking Transplanted Kidneys in Organ Recipients
Specific immunosuppressants and immunotherapy are not enough to prevent organ rejection in patients undergoing skin cancer treatment who have also received a kidney transplant, according to a clinical trial published in the Journal of Clinical Oncology.
-
First-year PA Student Awarded National Health Service Corps Scholarship
Lisa Namatame, a first-year Physician Assistant (PA) student, was recently awarded a scholarship from the National Health Service Corps Scholarship Program supported by the U.S. Department of Health and Human Services’ Health Resources and Services Administration.
-
Renowned Pulmonologist and Accomplished Clinical Educator Named Inaugural Director of Center for Bedside Medicine
Brian Garibaldi, MD, MEHP, professor of Medicine and of Physiology at the Johns Hopkins University School of Medicine, has been named the Charles Horace Mayo Professor of Medicine and the inaugural director of the new Center for Bedside Medicine at Northwestern.
-
Cellular Therapy Increases Survival in Recurring B-cell Lymphoma
A two-year follow-up clinical trial found that a personalized cellular therapy treatment for relapsed or refractory B-cell lymphoma demonstrated high safety and improved overall survival in patients, according to findings published in Blood.
-
Outsmarting Chemo-Resistant Ovarian Cancer
Northwestern Medicine scientists have discovered the Achilles heel of chemotherapy-resistant ovarian cancer — its hunger for cholesterol — and how to sneakily use that to destroy it.
-
Engineered Heart Cells May Improve Understanding of Atrial Fibrillation
A multidisciplinary team of investigators have engineered a more accurate model for studying the underlying mechanisms of atrial fibrillation and treatment response, according to findings published in Science Advances.
-
Novel Pathway Explains the Escalation of Fear Responses
Scientists have discovered a neuronal pathway involved in how the brain encodes the transition to high-intensity fear response behaviors required for survival, according to a study published in Nature.
-
Calming Neurotransmitter Can Also Be Excitatory
A neurotransmitter previously thought to only calm neurons may also play a role in waking them up, according to a study published in the journal PLOS Biology, a discovery which upends conventional theories of how the neurotransmitter works in the brain.
-
Analysis of K99/R00 Pipeline Illustrates Systematic Disadvantages
An analysis of NIH training grants has illustrated systematic disadvantages among the trainees who receive the awards.
-
Study Shows Tiny ‘Twisters’ Move Cytoplasm Within Cells
Investigators at Northwestern Medicine and the Flatiron Institute have characterized how developing cells reorganize their cytoplasm as part of their growth, according to a study published in Nature Physics, a discovery which furthers the field’s understanding of basic cellular processes at the earliest stages of development.
-
Neuronal Diversity Impacts the Brain’s Information Processing
Northwestern Medicine investigators have revealed new insights into the impact of neuronal structural diversity on neural computation, the basis of brain function, according to a recent study published in the Proceedings of the National Academy of Sciences.
-
Rethinking the Burden of Cancer Treatments’ Side Effects
Even mild and moderate side effects can contribute to patients with cancer discontinuing their treatment, according to an analysis recently published in the Journal of Clinical Oncology.
